Trichloroethylene (TCE) is a widespread environmental toxicant with immunotoxic and neurotoxic potential. Previous studies have shown that continuous developmental exposure to TCE encompassing gestation and early life as well as postnatal only exposure in the drinking water of MRL+/+ mice promoted CD4 + T cell immunotoxicity, glutathione depletion and oxidative stress in the cerebellum, as well increased locomotor activity in male offspring. The purpose of this study was to characterize the effects of exclusively prenatal exposure on these parameters. Another goal was to investigate potential plasma oxidative stress/inflammatory biomarkers to possibly be used as predictors of TCE-mediated neurotoxicity. In the current study, 6 week old male offspring of dams exposed gestationally to 0, 0.01, and 0.1 mg/ml TCE in the drinking water were evaluated. Our results confirmed that the oxidized phenotype in plasma and cerebellum was maintained after exclusively prenatal exposure. A Phenotypic analysis by flow cytometry revealed that TCE exposure expanded the effector/memory subset of peripheral CD4 + T cells in association with increased production of pro-inflammatory cytokines IFN-g and IL-17. Serum biomarkers of oxidative stress and inflammation were also elevated in plasma suggesting that systemic effects are important and may be used to predict neurotoxicity in our model. These results suggested that the prenatal period is a critical stage of life by which the developing CNS and immune system are susceptible to long-lasting changes mediated by TCE.
Introduction
The generation of reactive oxygen species and/or depletion of the glutathione anti-oxidant system as evidenced by a decrease in the active form of glutathione (GSH) and an increase in the inactive oxidized disulfide (GSSG), enhances susceptibility to oxidative stress leading to organ-specific cell damage (Biswas et al., 2006; Bobyn et al., 2002; Filomeni et al., 2002) . This is especially evident during development and early life stages (Maffi et al., 2008; McLean et al., 2005; Noble et al., 2005) , and may represent a key process by which environmental toxicants influence neurotoxicity (Costa et al., 2015) . Glutathione, the major intracellular antioxidant in the brain, is derived from the transsulfuration pathway that intersects with the methionine cycle [reviewed in Folate, 2002] . Methionine forms S-adenosylhomocysteine (SAM) which, through the transfer of its methyl group, is converted to Sadenosylmethionine (SAH) and homocysteine. Homocysteine has an alternative fate. It can regenerate methionine for an additional cycle, or it can be used to produce cysteine which can feed glutathione synthesis. Thus, from a functional standpoint, deficits in any of these metabolites could lead to neurotoxicity by promoting cellular differentiation, gene expression, DNA methylation, and oxidative stress.
Aside from oxidative stress, inflammation including peripheral immune activation and/or the cytokines they release can also adversely impact CNS responses (Anthony et al., 2011; Deledi et al., 2015) . These cells and their mediators apparently cross the bloodbrain-barrier made more permeable by inflammation (Stolp et al., 2005) to promote neuroinflammation and alter behavior (Wilson et al., 2002) . Increased maternal cytokine release occurring during the perinatal period has been shown to increase the risk of offspring developing neurologic disease in adulthood (Hagberg et al., 2015) . Similarly, rodent models of maternal infection resulting in increased cytokines have been experimentally linked with adverse neurologic outcomes in offspring (Malkova et al., 2012) . Immune activation can also activate the kynurenine pathway (i.e., a by-product of the amino acid tryptophan) implicated in major depressive disorder (Hufner et al., 2015) , as well as the release of oxidative stress/inflammatory mediators such as 3-chlorotyrosine, by certain immune cells (Knutson et al., 2013) . Thus, systemic inflammation immune activation, and oxidative stress are closely linked and may act in concert to promote neurotoxicity.
Environmental toxicants with the ability to promote oxidative stress and inflammatory responses may be important from a neurotoxicological standpoint. One such toxicant is the organic solvent and environmental pollutant trichloroethylene (TCE). TCE is a widespread contaminant that has been used for several decades in many industrial, commercial, medical, and consumer applications. TCE use has declined in the US in recent years. However, due to improper disposal practices, this chemical has become a persistent soil and water pollutant, and areas of TCE contamination are still being revealed. Based on likelihood of exposure together with negative health impact TCE is consistently ranked 16th out of 275 pollutants on the Superfund list of hazardous chemicals (ASTDR, 1997) . Thus, human exposure to TCE remains a significant public health concern, and there is clearly a need to study the potential adverse health effect of TCE (Chiu et al., 2013) .
Several studies have implicated the brain and immune system, namely CD4 + T cells, as targets of developmental TCE toxicity.
Children exposed to TCE beginning in utero to a TCE-contaminated water supply had altered ratios of T cell subsets indicating T cell hyperactivity (Byers et al., 1988) . We and others have shown that TCE promoted expansion of activated/memory CD4 + T cells with a Th1-like pro-inflammatory phenotype (Peden-Adams et al., 2006; Blossom and Doss, 2007; Blossom et al., 2008; Gilbert et al., 2014) . In terms of neurotoxicity, studies by our lab and others have shown cerebellar and hippocampal neurotoxicity with exposure during the perinatal and postnatal periods of development associated with decreased learning and increased locomotor and exploratory activity (Blossom et al., 2012 (Blossom et al., , 2013 Taylor et al., 1985; Isaacson et al., 1990) . Children of mothers working with TCE during pregnancy had poorer visual acuity, as well as impaired motor coordination and behavior characterized by inattention and hyperactivity (Laslo-Baker et al., 2004; Till et al., 2001) . The mechanism by which developmental exposure to TCE imparts neurotoxicity is largely understudied. Several studies have shown that TCE induces oxidative stress (Ogino et al., 1991; Channel et al., 1998; Wang et al., 2009) . We have focused on oxidative stress responses in the brain associated with developmental TCE exposure. Before mechanism can be addressed, it is important to determine the most sensitive window of susceptibility for developmental TCE toxicity. Development of the immune system and the CNS in both humans and rodents spans throughout gestation and postnatally until adulthood suggesting that these systems, due to their extended period of maturation, may be particularly vulnerable to environmental stressors (Dietert and Piepenbrink, 2006; Rice and Barone, 2000) . Although many important neurodevelopmental processes are shaped prenatally (Lindahl et al., 2008) , the brain undergoes significant development postnatally, including transient periods of rapid or slow growth between birth and young adulthood (Gottlieb et al., 1977; Clancy et al., 2007; Dumas, 2005) . Thus, we hypothesized that the impact of TCE after prenatal-only exposure would be less robust than observed at other developmental periods. In contrast to our expectations, the findings of this study revealed that many effects associated with postnatal and/or early life exposure were maintained with prenatal TCE exposure. This study also revealed several potential plasma biomarkers that may potentially be used to monitor TCE-induced effects in the brain.
Materials and methods

Mice and TCE exposure
Gestational exposure to TCE in MRL+/+ mice has been described in detail (Blossom et al., 2008; Gilbert et al., 2014) . Pregnant females were assigned to 3 groups by stratified randomization and given ultrapure water with 0 (control), 0.01, or 0.1 mg/ml TCE (purity 99+% purchased from Sigma, St. Louis, MO). Water with 0 (control), 0.01, or 0.1 mg/ml TCE also contained 1% Alkamuls EL-620, an emulsifier consisting of ethoxylated castor oil (RhonePoulenc, Cranbury, NJ), a reagent used to solubilize the TCE. Maternal exposure to TCE-containing drinking water ended at birth [i.e., postnatal day zero (PND0)]. Litters were standardized at birth to consist of no more than 8 pups per litter. At $6 weeks of age, one randomly selected male mouse from each litter was used for all assays described below. All studies were approved by the Animal Care and Use Committee at the University of Arkansas for Medical Sciences.
Open field activity
All open field tests were conducted and analyzed using EthoVision XT 8.0 video-tracking software (Noldus Information Technology, Inc., Leesburg, VA). This system digitizes the video signal obtained from a color LCD camera mounted on the ceiling to determine the spatial coordinates of the mouse's location within the testing arena. From these coordinates, the distance traveled per unit time, the number of times a defined zone is entered and the amount of time within a zone was calculated. The behavioral tests were conducted under standard lighting conditions in an isolated room to minimize the interference of noise. For locomotor activity, mice were placed in an unfamiliar testing arena (45 Â 45 cm 2 ) and the distance traveled (cm) was measured in a 20 min testing period. Other outcomes in the open field included total time in the center, number of times in the center, latency to enter the center zone, and velocity. Each behavior was calculated by the EthoVision software for each individual mouse.
HPLC quantification of plasma and cerebellum metabolites
Mice were deeply anesthetized with inhaled isoflurane (Fisher). A blood sample was collected using retro-orbital sampling, placed in heparinized tubes and processed to obtain plasma. Mice were then sacrificed and the cerebellum was dissected from the whole brain tissue and flash frozen in liquid nitrogen. Samples were stored at À80 C until extraction for metabolite detection. The methodological details have been described previously (Melnyk et al., 1999) . The analyses were performed using HPLC with a Shimadzu solvent delivery system (ESA model 580) and a reverse phase C18 column (3 mm; 4.6 Â 150 mm, Phenomenex, Inc., Torrance, CA). Brain extracts were directly injected onto the column using a Beckman Autosampler (model 507E). All metabolites were quantified using a model 5200A Coulochem II and CoulArray electrochemical detection system (ESA, Inc., Chelmsford, MA) equipped with a dual analytical cell (model 5010), a 4 channel analytical cell (model 6210) and a guard cell (model 5020). The levels or concentrations of thiol metabolites, methyl group donor metabolites, and oxidative stress biomarkers in cerebellum or plasma were calculated from peak areas and standard calibration curves using HPLC software. Intracellular results are expressed as nmol/mg of protein using the BCA Protein Assay Kit (Pierce, Rockford, IL). Free reduced glutathione (GSH), oxidized glutathione (GSSG), cysteine (CyS) and cystine (CySSCy) are expressed as levels (moles) per milligram of protein in cerebellum or as molar concentrations in plasma. Plasma was evaluated for thiols and methyl donor metabolites, as well as for 3-nitrotyrosine (3-NT), 3-chlorotyrosine (3-CT), tyrosine and tryptophan. Levels were expressed as micromoles or nanomoles per liter. The percentage of oxidized glutathione is expressed in absolute glutathione equivalents and was calculated as [100 Â 2 Â GSSG/ (GSH + 2GSSG)] where 2Â GSSG is the glutathione equivalents in oxidized glutathione and GSH is the glutathione level or concentration (Melnyk et al., 2011) . Total GSH concentrations (micromolar in plasma) or levels (nmol/mg cellular protein) were determined by calculation from free GSH concentrations or levels, i.e., total GSH = GSH + 2GSSG. Likewise, total CyS concentrations or levels were determined by calculation from free cysteine and cysteine concentrations or levels, i.e., total CyS = CyS + 2CySSCy.
Phenotypic analysis of spleen cells
The phenotypic analysis of 30,000 events per sample was carried out using a CyFlow ML (Partec GmbH, Munster, Germany) as described previously using monoclonal antibodies from BD Biosciences or eBioscience (Blossom et al., 2008) . The data (percentage of cells) are presented as individual mice represented in scatter plots. Fluorescence Minus One controls and isotype Ig controls were included.
Cytokine analysis
CD4
+ T cells were isolated from spleen cell suspensions from individual mice using a Dynabeads FlowComp Mouse CD4 kit (Invitrogen). CD4 + T cells were stimulated with immobilized anti-CD3 antibody and anti-CD28 antibody for 18 h as described (Gilbert et al., 2006) . Culture supernatants were then collected for cytokine evaluation using Luminex multiplex kits for mouse IFN-g, IL-2, IL-4, IL-10, IL-17, and TNF-a (Millipore, Billerica, Massachusetts).
Statistical analysis
Statistical analysis for all data except for some behavioral comparisons was performed using GraphPad Prism 5.0 (LaJolla, CA). All data were expressed as mean AE standard deviation (SD) or AEstandard error of the mean (SEM) where indicated. One way ANOVA with a Dunnett's Multiple Comparison Test was used to determine significant differences between vehicle control vs. lowor high-dose TCE treatment groups for experimental outcomes. Treatment-related differences for those outcomes were considered to be significant at p 0.05. When the means were not significantly different among treatment groups, Bartlett's tests were employed to compare the variability within each exposure group. Variances were considered to be significantly different at p 0.05. Pearson product-moment correlation coefficients were used to determine the relationship between levels of GSH in cerebellum and plasma. p values 0.05 were considered significant.
Behavioral outcomes were estimated from generalized linear mixed models (GLMM) accounting for the underlying distribution of each outcome. For continuous-type outcomes (i.e. distance traveled, time in the zone, number of times the mouse enters the center zone), a linear mixed model (LMM) assuming a normal distribution was utilized. For count-measuring variables (i.e. frequency to enter the zone), a GLMM assuming a Poisson distribution was utilized to account for the count data. The model also included TCE treatment and time as fixed effects, and a random intercept accounting for the correlation within each subject. A nominal significant level with p-value 0.05 was considered to be statistically significant. Analysis of behavioral outcomes was completed using R version 3.0.2 (Vienna, Austria: R Development Core Team).
Results
Characteristics of dams and offspring
As shown in Table 1 , prenatal exposure to TCE did not alter the weight of the dams or affect the average volume of water (ml) consumed per day. The amount of TCE (mg/kg/day) was based on average water intake, body weight, and a calculated average of $20% TCE degradation in the water bottles. There were no differences in offspring birth and physical parameters including the number of litters, litter size, and age/weight at sacrifice.
Prenatal TCE exposure increases locomotor activity in offspring
Open field tests were conducted to measure locomotor activity in control and TCE-exposed mice. As shown in Fig. 1A , mice exposed to TCE traveled an average distance of $81 cm and $55 cm greater than control mice (0.01 and 0.1 mg/ml respectively; overall p value = 0.03). Mice exposed to 0.01 mg/ml TCE traveled a total distance of 6883 cm which represented a 1622 cm increase over that observed in mice from the control group (p = 0.01). Mice treated with 0.1 mg/ml TCE traveled a total distance of 6366 cm which represented a 1105 cm increase over controls. This effect did not reach statistical significance (p = 0.06).
The distance traveled was summed for each mouse per group in 2 min (i.e., 120 s) epochs during the 20 min testing period. Fig. 1B shows that on average, mice exposed to 0.01 mg/ml TCE traveled significantly further than controls (p = 0.02, 0.03, and 0.02 for 120, 240, and 360 s epochs, respectively). Mice exposed to 0.1 mg/ml TCE traveled further compared to controls toward the end of the testing period (i.e., at 960 sec; p = 0.02). Mice in both TCE exposure groups traveled a greater distance as compared to control mice during the last two minutes of the testing period (p = 0.01 for 0.01 and 0.1 mg/ml TCE). Table 2 summarizes the result of additional behavioral tasks evaluated in the open field. The average speed at which the mice traveled (i.e., velocity) did not differ significantly among the groups of mice. The average time spent in the center of the testing arena and the number of times the test mouse entered the virtual center zone of the testing arena during the testing period did not significantly differ among the groups of mice. In contrast, latency to enter the virtual center zone was decreased in mice exposed to 0.01 mg/ml TCE (p = 0.01). 
Prenatal TCE exposure alters brain redox homeostasis in the cerebellum
The data presented in Table 3 depict the concentrations of reduced GSH, GSSG, the glutathione redox (GSH/GSSG) ratio, and the percentage of oxidized glutathione equivalents in the cerebellum. Compared to vehicle-treated control mice, mean GSH levels in cerebellum from mice treated with 0.1 mg/ml TCE were decreased (p = 0.006). In contrast, the average concentration of GSSG among groups was not significantly different. The percent oxidized glutathione, expressed as glutathione equivalents (100 Â 2 GSSG/[GSH + 2GSSG]) is an indicator of intracellular glutathione redox potential (Lenton et al., 1999) . The percent oxidized glutathione was significantly increased by 41% (p = 0.02) in mice treated with 0.1 mg/ml TCE, relative to controls. This difference was similarly reflected by a 44% decrease in the GSH/ GSSG ratio (p = 0.04).
Also shown in Table 3 are concentrations of the major extracellular redox couple, CyS, the rate limiting precursor for glutathione synthesis, and the oxidized form of CyS (i.e., CySSCy) and the ratio of the pair (CyS/CySSCy). The levels of CyS were significantly reduced in with both concentrations of TCE as compared to controls by 52% (p = 0.011) and 55% (p = 0.0004) for 0.01 and 0.1 mg/ml TCE, respectively. While the mean concentration of CySSCy was not significantly different among the treatment groups, the ratio of CyS to CySSCy was significantly decreased by 45% (p = 0.01) and 38% (0.014) for 0.01 mg/ml and 0.1 mg/ml TCE, respectively. Compared to controls, total CyS (CyS + 2Â CySS) was also significantly lower in the 0.1 mg/ml TCE group (p = 0.02).
Prenatal TCE exposure alters transsulfuration and transmethylation metabolites in plasma
Plasma levels of redox and methyl metabolites in the interrelated transmethylation pathway were also examined. Free reduced GSH is a measurement of unbound GSH remaining after protein precipitation and an indication of readiness to neutralize free radicals. As shown in Table 4 there was a significant $46% decrease (p = 0.0002) in free reduced GSH in the plasma of mice exposed prenatally to 0.1 mg/ml TCE. The mean concentration of GSSG, was significantly increased by 43% relative to controls in the 0.1 mg/ml TCE dose group (p = 0.02). Correspondingly, free plasma GSH/GSSG ratios were significantly lower in mice treated with 0.1 mg/ml TCE compared to controls (by 65%; p = 0.005). The percent oxidized glutathione was significantly increased in mice treated with 0.1 mg/ml TCE compared to controls (p = 0.004). Statistical significance was not reached with the 0.01 mg/ml dose of TCE. Calculated total GSH (i.e., GSH + 2GSSG) was not significantly increased with TCE exposure.
Free CyS levels were not statistically different among the groups of mice. In contrast, CySSCy was significantly elevated in mice exposed to 0.1 mg/ml TCE ($26%; p = 0.02). The CyS/CySSCy thiol redox couple ratio was significantly different (p = 0.009) with 0.1 mg/ml TCE exposure compared to controls. Mean total CyS levels were significantly higher with exposure to the highest dose of TCE (p = 0.01). For the 0.01 mg/ml group, the means were not statistically significant (p = 0.28). However, when a Bartlett's test for variance was conducted, there was an increase in the variation (p = 0.02) with exposure to this dose. Selected plasma methyl metabolites are shown in Table 5 . There was no effect of TCE on plasma methionine levels. However, mean levels of SAM, were decreased by $29% with the highest dose of TCE (p = 0.01). In contrast, SAH was unchanged. However, there was a significant decrease in the SAM/SAH ratio with exposure to the highest dose of TCE (p = 0.02).
3.5. Positive association between oxidative endpoint GSH in plasma and cerebellum Behavioral tests were evaluated with one randomly selected male mouse per litter; n = 10 for controls, n = 8 for 0.01 mg/ml TCE, and n = 9 for 0.1 mg/ml TCE. The mean AE SEM are presented in the graphs. *Statistically significant compared with control groups (p 0.05). 3.6. 3-Nitrotyrosine increased in cerebellum and plasma Fig. 3 presents the concentrations of 3-NT, a protein nitrosative/ oxidative stress biomarker in plasma and cerebellum. In cerebellum (Fig. 3A) , 3-NT levels were significantly increased in mice exposed prenatally to 0.1 mg/ml TCE relative to controls (p = 0.02). 3-NT concentrations were significantly increased in plasma by 54% (p = 0.005) for 0.01 mg/ml TCE and 57% (p = 0.006) for 0.1 mg/ml TCE (Fig. 3B) .
Prenatal TCE exposure increased plasma inflammatory biomarkers
The increase in 3-NT with TCE exposure appeared to be more robust in plasma than in cerebellum. Thus, we investigated an additional inflammatory/oxidative stress-related biomarker, 3-CT, in plasma. As shown in Fig. 4A . The mean concentration of 3-CT in the plasma was increased by 52% (p = 0.0001) for 0.01 mg/ml TCE and 72% (p = 0.006) for 0.1 mg/ml TCE relative to controls. We also examined plasma levels of tryptophan, an amino acid that is a precursor to serotonin with known immunomodulatory properties associated with neurological disorders (Oxenkrug et al., 2010) .
Prenatal TCE exposure significantly increased plasma levels of tryptophan (p = 0.01 for 0.01 mg/ml TCE and p = 0.006 for 0.1 mg/ml TCE) (Fig. 4B) . As a control, the amino acid tyrosine was evaluated. Levels of tyrosine were not statistically different among the groups (Fig. 4C) . n Con trol 0.01 mg/ml TCE 0.1 mg/ml TCE Fig. 2 . Positive correlation between GSH in plasma and cerebellum.
Presented is a correlation plot of the levels of plasma and cerebellar GSH. Each symbol represents an individual mouse in each treatment group.
Prenatal TCE exposure increases population of memory CD4 + T cells in adult mice
Results from the plasma evaluation indicated that prenatal TCE exposure induced a systemic pro-oxidative and pro-inflammatory state. We therefore evaluated phenotypic and functional characteristics of CD4 + T cells that are associated with TCE-induced immunotoxicity. Based on differential cell surface expression of CD62L and CD44 we, in addition to naïve/resting CD4 + T cells, evaluated two memory CD4 + T cell populations that are important in inflammatory responses (Pepper and Jenkins, 2011) . The phenotypic analysis of the CD4 + T cells revealed an interesting expression pattern. The graph in Fig. 5A shows a statistically significant increase in the mean percentage of central memory CD4 + T cells in the spleen with exposure to the highest dose of TCE (12.4% vs. 19.4%; control vs. 0.1 mg/ml TCE exposure, respectively; p = 0.04). As shown in Fig. 5B . TCE exposure did not significantly alter the mean percentage of naïve CD4 + T cells or effector memory CD4 + T cells in the spleen (Fig. 5C ) relative to controls. However, the variance was significantly different for these cell populations.
3.9. Prenatal TCE exposure alters CD4 + T cell cytokine production CD4 + T cell production of cytokines including IFN-g, IL-2, IL4, IL-10, IL-17, and TNF-a were examined as functional biomarkers of prenatal TCE exposure. Prenatal TCE exposure alone was not sufficient to alter the mean cytokine production by CD4 + T cells over control mice. However, as shown in Fig. 6 the variance in CD4 + T cell-secreted IFN-g levels were statistically significant comparing 0.1 mg/ml TCE vs. controls (p = 0.05). As for IL-17, variability was markedly increased with both concentrations of TCE (p = 0.03 and 0.002 with 0.01 and 0.1 mg/ml TCE, respectively). The mean and variance ratios of CD4 + T cell derived TNF-a, IL-2, IL-10, and IL-4 were not statistically different among the treatment groups.
Discussion
The goal of this study was to determine if TCE-induced neurotoxicity was sustained in after a period of exclusively prenatal exposure. The cerebellum was selected for neurochemical analysis to compare our previous findings using identical doses of TCE with postnatal/early life TCE exposure. In addition, the cerebellum is reportedly sensitive to oxidative stress/redox impairment with toxicant exposure (Giordano et al., 2008; LeDuc et al., 2015) . This study provides novel evidence that the effects of prenatal TCE exposure are maintained later in life.
The doses used in the current study were relevant to actual human exposure. The lowest concentrations of TCE used (0.01 mg/ml or 10 ppm) were considerably lower than acceptable human occupational exposure. It has been estimated that approximately 3.5 million workers are exposed to TCE in the workplace and it can be presumed that a significant proportion of these workers are women of childbearing age (Wu and Schaum, 2000) . Although our study used doses higher than the EPA's Maximum Contaminant Level for public drinking water (5 ppb), TCE has been detected in contaminated well water at levels up to 1.4 ppm (ATSDR, 1997). Since the mice were exposed prenatally, TCE metabolism by the pregnant dams may be enhanced thereby reducing the bioavailability of TCE and its metabolites to the developing fetus as shown with other toxicants (Legraverend et al., 1984) . Thus, the mice in utero may have been exposed to doses of TCE even lower than estimated.
The results implied that the time of gestation may be important risk consideration for TCE-exposed human populations. As such, human contact with TCE can occur at all stages of life. Exposure to the fetus has been demonstrated by the finding that TCE and its metabolites cross the placenta (Laham, 1970) . Exposure to TCE during infancy can be implied due to its detection in breast milk samples (Beamer et al., 2012) . Very little is known about developmental TCE toxicity in humans. Most epidemiological studies of developmental TCE exposure have been confined to analysis of birth outcomes including cardio-teratogenicity, eye anomalies, perinatal deaths, gestational size, and neural tube defects (Bove et al., 2002) . While these investigations are important, there is a need to document additional health effects that may manifest from exposure during different developmental windows.
We hypothesized that the effects observed in 6 week old male mice after exclusively prenatal exposure would be modest, or even absent after a considerable period of exposure cessation. While not all of the results were statistically significant, the overall direction of our results showed an effect with prenatal TCE exposure. The increase in locomotor activity was sustained with prenatal TCE exposure. This became more apparent when the time intervals were broken into 2 min bins. In contrast, other open-field behaviors measured in the present study were not significantly different between TCE-exposed mice and controls. One notable exception was the decreased latency to approach the center of the testing arena observed in mice exposed to the highest dose of TCE. Open field behaviors were more robust with postnatal/early life exposure to identical doses of TCE (Blossom et al., 2013) 0.8 * ** Fig. 3 . 3-Nitrotyrosine levels in the cerebellum and plasma were elevated with prenatal TCE exposure. 3-Nitrotyrosine were measured in the cerebellum (A) and plasma (B) of one randomly selected male mouse per litter (n = 6 for all treatment groups) using HPLC with electrochemical detection as described in the Materials and Methods section. Results are reported as nmol/mg protein (cerebellum) or nM (plasma). The mean AE SD and range are presented in the graphs. Results are statistically significant compared with control groups (*p 0.05 and **p 0.005).
is possible that behavioral responses are enhanced during exposure periods when brain is reportedly more sensitive to environmental stressors.
Impaired motor activity has been associated with glutathione depletion (Diaz-Hung et al., 2014) , and nearly all sulfur compounds measured were significantly lower in cerebellum in TCE treated mice indicating a generalized oxidized state. Especially interesting were the TCE-mediated alterations in the major extracellular redox couple, CyS and CySSCy. The synthesis of glutathione in the brain is unique in that cells in the brain cannot generate CyS. Thus the brain is dependent on the liver to synthesize and export CyS for uptake and utilization by astrocytes for glutathione synthesis (Atawa et al., 1995; Lu, 1998) . CyS is converted to CySSCy in the oxidizing environment in the plasma where it is converted to CyS and transported to the brain for intracellular glutathione synthesis. Because CyS is the precursor for glutathione synthesis, the availability of extracellular CySSCy and CyS determines intracellular glutathione concentrations and resistance to toxic compounds in astrocytes and neurons, respectively. Indeed, toxicants, like methyl mercury, have been shown to inhibit the biosynthesis of GSH by inhibiting the uptake of CyS by astrocytes (Shanker et al., 2002) . Whether TCE and/or its metabolites promote oxidative stress by a similar manner is not known.
Biomarkers of methylation capacity were evaluated in the current study because of their close association to glutathione synthesis cellular methylation reactions. Methionine is an immediate precursor to SAM, the major methyl donor. Unlike with postnatal/early life TCE exposure, methionine was not altered in cerebellum or plasma with TCE exposure in the current study. However, in plasma SAM and the SAM/SAH ratio frequently used as an indicator of cellular methylation capacity was decreased significantly with TCE exposure which would predict reduced methylation potential. Since we did not evaluate DNA methylation in this study, the implication of this finding is not clear. A reduction in SAM together with the maintenance of effects after exposure cessation suggested that epigenetic factors might be involved.
Our results provided evidence of inflammation and immunomodulation with prenatal TCE exposure. TCE increased the mean percentage of central memory CD4 + T cells in offspring and, in at least 33% of the mice, the effector memory T cell subset was increased as reflected by the variance ratio. Effector memory subpopulations express homing receptors such as CD62L that help them migrate from the lymphoid organs to inflammatory sites (e.g., lung, liver or gut) to participate in immune responses. These cells produce cytokines including IL-17 and IFN-g within several hours of activation. Central memory cells, unlike memory effector cells, are not required for immediate effector function. Instead these cells proliferate in spleen and lymph nodes until they receive homing signals to migrate to inflammatory sites. Thus, toxicants like TCE that expand these populations of cells might contribute to uncontrolled inflammation leading to tissue pathology including neuropathology. Since a pathologic examination was not conducted in this study, it was not possible to determine the homing location of these memory CD4 + T cells.
The mean levels of the pro-inflammatory cytokines, IFN-g and IL-17 were not statistically different among exposure groups. However, when statistical tests to evaluate differences in the variance ratios were employed the results showed that TCEexposed mice showed more variation in IFN-g and IL-17 than controls. The biological relevance of this result is important to consider. This result might suggest that in certain mice within the TCE treatment groups, the CD4 + T cells may have converted to from a naïve to memory to a proinflammatory phenotype. Th1-like responses are known to be highly plastic and can be influenced by the local inflammatory cytokine milieu. Thus, conversion from a naïve phenotype to a pathogenic, disease-promoting Th1 phenotype may vary within individual mice in the same group as shown in some mouse models of autoimmune disease (Bending et al., 2015) .
It is important to identify potential plasma biomarkers that may be used to predict toxicant-induced effects in the brain. Several studies have established linkages between plasma oxidative stress/ altered glutathione redox state and inflammatory biomarkers in the blood with some neurological and psychiatric disorders including Alzheimer's disease ( Plasma samples were evaluated from one randomly selected male mouse per litter (n = 6 for all groups) for the concentrations of 3-CT (A), tryptophan (B), and tyrosine (C) using HPLC with electrochemical detection as described in the Materials and Methods section. Results are reported as nM (3-CT) or mM (tyrosine and tryptophan). The mean + SD and range are presented in the graphs. Results are statistically significant compared with control groups (*p < 0.05 and ***p < 0.0005).
disease (Martin and Teismann, 2009 ), mood disorders (Duffy et al., 2015; Andreazza et al., 2008) , and autism spectrum disorders (ASDs; James et al., 2004; Rose et al., 2012) . However, the brain has remained relatively understudied due to obvious difficulties associated with obtaining this tissue and technical issues with the use of post-mortem brain. There was a positive correlation between GSH in plasma and cerebellum with TCE exposure.
Although this biomarker alteration is common to many toxicants, it is important to study measurable markers in the blood as a surrogate for possible toxicant-induced adverse effects in the brain. We emphasize that TCE itself has not been implicated in promoting human neurologic disease, however; identifying environmental stressors that may underlie biological processes common to many different neurologic diseases is important in understanding neurotoxicity of TCE.
Along this line, we observed increased 3-NT in both plasma and cerebellum. 3-NT is an oxidized protein tyrosine derivative that provides a stable biochemical footprint of oxidative protein damage. 3-NT is formed from peroxynitrite, a highly reactive free radical generated from nitric oxide and superoxide (Butterfield and Sultana, 2008; Nakazawa et al., 2000) . The presence of this biomarker has been detected in brain tissue from patients with neurologic disease (Mythri et al., 2011; Butterfield et al., 2006; Sajdel-Sulkowska et al., 2009) . The tyrosine derivative, 3-CT, like 3-NT is a stable post-translational modification of protein tyrosine residues and a biomarker of inflammation. 3-CT is generated from hypochlorous acid, a potent chlorinating oxidant derived from myeloperoxidase in activated immune cells during inflammation (Knutson et al., 2013) . Elevated myeloperoxidase is also associated with neurological and autoimmune disorders (Green et al., 2004; Choi et al., 2005; Nagra et al., 1997) . Additionally, myeloperoxidase promotes Th1 (e.g., IL-17 and IFN-g producing immune cells) associated with autoimmune disease (Gan et al., 2010) .
Plasma levels of the amino acid tryptophan were included as a plasma biomarker based on its role in inflammation. Cytokines including T cell-derived IFN-g are among the strongest inducers of indoleamine dioxygenase (IDO) which causes tryptophan to covert to kynurenine rather than serotonin. Kynurenine inhibits tryptophan transport into the brain and stimulates the production of additional IDO (Oxenkrug, 2010; Maes et al., 2007) . Kynurenine metabolites have been associated with reduced striatal volume in the brain of depressed individuals (Savitz et al., 2015) , and altered tryptophan metabolism promotes cognitive errors and anxiety in rats (Asor et al., 2015) . In mice neonatally treated with kynurenine demonstrated increased locomotor activity as adults (Liu et al., 2014) . Thus, the increased tryptophan observed with TCE exposure in our model may provide an interesting mechanistic link to the reported neurochemical and behavioral changes associated with the tryptophan/kynurenine pathway. Taken together these findings underscore the importance of investigating peripheral inflammatory biomarkers that may be used to predict neurotoxicity.
Among the four plasma biomarkers evaluated in the present study not directly linked to the transsulfuration/transmethylation pathway (i.e., 3-NT, 3-CT, tyrosine, and tryptophan) only 3-NT was evaluated in both plasma and cerebellum due to sample limitations. Our results revealed that 3-NT was significantly increased relative to controls with exposure to both high and low concentrations of TCE in plasma, as opposed to cerebellum in which the TCE effects was only seen with the highest dose. The meaning of this finding is not clear, but the significant increase in plasma biomarkers (3-NT, 3-CT, and tryptophan) to both doses of TCE might predict a direct peripheral effect (e.g., the liver or immune system) rather than serving as a specific biomarker of neurotoxicity. It is also possible that the cerebellum may not reflect responses that are occurring in other regions of the brain. Indeed open field behavior appeared to be more robust in the low dose group. This issue can be addressed in future studies by evaluating these biomarkers in other relevant brain regions to address correlation between brain and blood markers of neurotoxicity.
There is very little mechanistic information regarding developmental TCE exposure and neurotoxicity. The findings reported in the current study underscore the need for additional studies in this area. In addition to direct effects of TCE and or its metabolites in the brain, TCE may additionally exert its neurotoxic effects indirectly by activating CD4 + T cells to produce pro-inflammatory cytokines and other inflammatory mediators in the periphery to promote oxidative stress, neuroinflammation, and altered behavior. Studies to further characterize neuroinflammation in additional brain regions in association with a larger repertoire of behaviors with developmental exposure are currently underway. Possible maternal factors including epigenetic regulation of neurobehavior by TCE exposure are also important considerations for future study.
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